Learn Anytime, Anywhere
The core of AD-LEARN is delivered through the ESMIT eLearning platform, the educational hub of the European Association of Nuclear Medicine (EANM). Our 10 online modules are fully CME-accredited and designed to be accessible, interactive, and practical for busy healthcare professionals.
What You Will Find
AD is a neurodegenerative disorder defined by a spectrum of clinical and biological features:
10 comprehensive modules (60–90 minutes each), covering the complete biomarker-based diagnostic approach in neurocognitive disorders.
Each module includes:
- expert lectures (multimedia-rich, evidence-based),
- case-based learning (clinical scenarios reflecting daily practice),
- interactive quizzes for pre- and post-assessment.
Certification: After completing all modules and assessments, participants receive an official ESMIT/EANM certificate.
Modules can be completed at your own pace over a 3-year access period, allowing flexible learning.
How to Access
Visit the ESMIT eLearning platform: esmit.eanm.org
Log in with your MyEANM account:
- If you are already an EANM member, you can use your existing login details.
- If you are not a member, you can create a free MyEANM account to access the platform.
Once logged in, search for AD-LEARN modules in the Online Learning section.
Register for the course package. Modules will be released between October 2025 and May 2026 and will remain available until 2029.
Complete the modules at your own pace. Your progress is saved automatically, so you can pause and return anytime.
Why eLearning with AD-LEARN?
Flexible
Learn when and where it suits you.
Accredited
Earn CME credits recognised across Europe (UEMS-EACCME).
Interactive
Engage with cases, not just lectures.
Accessible
All material remains available for three years after launch.